Inspire Medical Systems, INC Form 4 insider transactions

Inspire Medical Systems' Chief Product and Innovation Officer, John Rondoni, reported a tax-related disposition of 327 common shares.

Inspire Medical Systems' Interim CFO, Richard Buchholz, reported a disposition of 327 shares for tax withholding related to a restricted stock unit award.

Inspire Medical Systems Director Gary Lee Ellis acquired 304 shares of common stock at $96.47 per share on January 15, 2026, as part of the company's non-employee director compensation policy.

Inspire Medical Systems Director Georgia Melenikiotou acquired 180 shares of common stock valued at $96.47 per share as part of her compensation.

Inspire Medical Systems Director Shelley G. Broader acquired 200 shares of common stock at $96.47 per share, opting for equity over cash compensation.

Inspire Medical Systems Director Casey M. Tansey acquired 181 shares of common stock in lieu of cash fees, increasing direct beneficial ownership to 22,416 shares.

Inspire Medical Systems' Chief Product and Innovation Officer, John Rondoni, sold 109 shares of common stock for $100 per share under a pre-arranged trading plan.

Inspire Medical Systems Director Shawn McCormick sold 1,200 shares of common stock for $139 per share under a pre-arranged 10b5-1 trading plan.

Shawn McCormick, a Director at Inspire Medical Systems, Inc., sold 2,000 shares of common stock for $127.48 per share under a pre-arranged trading plan.

Inspire Medical Systems Director Myriam Curet reported inadvertent stock transactions, including a short-swing profit repayment of $4.97 to the company.

Inspire Medical Systems Director Georgia Melenikiotou acquired 229 shares of common stock at $78.84 per share as part of her compensation, increasing her direct beneficial ownership to 3,986 shares.

Inspire Medical Systems Director Casey M. Tansey acquired 221 shares of common stock as part of compensation.

Inspire Medical Systems Director Gary Lee Ellis acquired 372 shares of common stock at $78.84 per share, increasing his beneficial ownership to 6,454 shares.

Inspire Medical Systems Director Shelley G. Broader acquired 245 shares of common stock at $78.84 per share as part of her compensation.

Inspire Medical Systems' Chief Financial Officer, Richard Buchholz, sold 11,000 shares of common stock for $93.39 per share.

Inspire Medical Systems CFO Richard Buchholz exercised stock options and adjusted his common stock holdings, including shares withheld for tax obligations.

Inspire Medical Systems, Inc. Director Gary Lee Ellis acquired 221 shares of common stock at $128 per share on July 15, 2025, as part of the company's non-employee director compensation policy.

Inspire Medical Systems, Inc. Director Casey M. Tansey acquired 133 shares of common stock at $128 per share as part of the company's non-employee director compensation policy.

Inspire Medical Systems, Inc. Director Shelley G. Broader acquired 148 shares of common stock at $128 per share as part of her compensation, increasing her total beneficial ownership to 4,122 shares.

Inspire Medical Systems Director Georgia Melenikiotou acquired 131 shares of common stock at $128 per share as part of the company's non-employee director compensation policy.

Shawn McCormick, a Director at Inspire Medical Systems, Inc., exercised stock options to acquire 4,000 shares of common stock at $16 per share, increasing his direct beneficial ownership.

John Rondoni, Chief Product and Innovation Officer at Inspire Medical Systems, sold 1,734 shares of common stock at a price of $149.38 on May 19, 2025.

Gary Ellis, a director at Inspire Medical Systems, Inc., reports the acquisition and disposal of common stock and an award of Restricted Stock Units (RSUs).

Director Shelley G. Broader acquired 1,266 shares of Inspire Medical Systems, Inc. through a grant of Restricted Stock Units (RSUs) on May 1, 2025.

Director Shawn McCormick reports acquisition of restricted stock units and sale of common stock in Inspire Medical Systems.

Director Myriam Curet acquired 1,266 Restricted Stock Units (RSUs) in Inspire Medical Systems, Inc.

Georgia Melenikiotou, a director at Inspire Medical Systems, reported the acquisition of restricted stock units and subsequent disposal of shares to cover tax obligations.

Director Casey M. Tansey of Inspire Medical Systems, Inc. reports acquisition of restricted stock units and adjustments to beneficial ownership.

Director Dana G. Mead Jr. of Inspire Medical Systems, Inc. reports acquisition of 1,266 Restricted Stock Units (RSUs) on May 1, 2025.

Director Cynthia Burks reports acquiring 1,266 Restricted Stock Units (RSUs) in Inspire Medical Systems, Inc.